Epigenetic Therapy in Human Choriocarcinoma
Because epigenetic alterations are believed to be involved in the repression of tumor suppressor genes and promotion of tumorigenesis in choriocarcinomas, novel compounds endowed with a histone deacetylase (HDAC) inhibitory activity are an attractive therapeutic approach. HDAC inhibitors (HDACIs) we...
Main Authors: | Hisashi Narahara, Noriyuki Takai |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2010-09-01
|
Series: | Cancers |
Subjects: | |
Online Access: | http://www.mdpi.com/2072-6694/2/3/1683/ |
Similar Items
-
Histone Deacetylases and their Inhibitors in Cancer Epigenetics
by: Kelly N. Hassell
Published: (2019-11-01) -
The Potential Role of Epigenetic Drugs in the Treatment of Anxiety Disorders
by: Peedicayil J
Published: (2020-03-01) -
Epigenetic therapy of cancer
by: Stankov Karmen M., et al.
Published: (2014-01-01) -
The Role of Dietary Histone Deacetylases (HDACs) Inhibitors in Health and Disease
by: Shalome A. Bassett, et al.
Published: (2014-10-01) -
Epigenetic Regulation of Autophagy: A Path to the Control of Autoimmunity
by: Jessica C. Hargarten, et al.
Published: (2018-08-01)